APA

Xu C., Liu Y., Jiang D., Li Q., Ge X., Zhang Y., Huang J., Su J., Ji Y., Hou J., Lu S., Hou Y. & Liu T. (20180305). Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. : Oncotarget.

Chicago

Xu Chen, Liu Yalan, Jiang Dongxian, Li Qian, Ge Xiaowen, Zhang Ying, Huang Jie, Su Jieakesu, Ji Yuan, Hou Jun, Lu Shaohua, Hou Yingyong and Liu Tianshu. 20180305. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. : Oncotarget.

Harvard

Xu C., Liu Y., Jiang D., Li Q., Ge X., Zhang Y., Huang J., Su J., Ji Y., Hou J., Lu S., Hou Y. and Liu T. (20180305). Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. : Oncotarget.

MLA

Xu Chen, Liu Yalan, Jiang Dongxian, Li Qian, Ge Xiaowen, Zhang Ying, Huang Jie, Su Jieakesu, Ji Yuan, Hou Jun, Lu Shaohua, Hou Yingyong and Liu Tianshu. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. : Oncotarget. 20180305.